prednisone has been researched along with olanzapine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brown, ES; Carmody, TJ; Chamberlain, W; Dhanani, N; Paranjpe, P; Sargeant, M | 1 |
| Kahn, DA; Pelic, C; Shibley, H | 1 |
| Dickmann, JR; Eversheim, F | 1 |
| Kenedi, C; West, S | 1 |
| Akid, I; Bienvenu, OJ; Nanavati, J; Nesbit, S; Smith, TJ | 1 |
3 review(s) available for prednisone and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Lithium Compounds; Lorazepam; Methylprednisolone; Olanzapine; Polyarteritis Nodosa; Prednisone; Psychoses, Substance-Induced | 2014 |
Prevention of Steroid-Induced Neuropsychiatric Complications With Neuroleptic Drugs: A Review.
Topics: Adrenal Cortex Hormones; Antipsychotic Agents; Humans; Olanzapine; Prednisone | 2022 |
1 trial(s) available for prednisone and olanzapine
| Article | Year |
|---|---|
An open-label trial of olanzapine for corticosteroid-induced mood symptoms.
Topics: Adrenal Cortex Hormones; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neurologic Examination; Olanzapine; Prednisone; Prospective Studies; Texas; Treatment Outcome | 2004 |
6 other study(ies) available for prednisone and olanzapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A case of paranoid schizophrenia complicated by scleroderma with associated esophageal dysmotility.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Case Management; Commitment of Mentally Ill; Cyclophosphamide; Diagnosis, Differential; Drug Interactions; Enteral Nutrition; Esophageal Achalasia; Female; Haloperidol; Humans; Immunosuppressive Agents; Olanzapine; Patient Acceptance of Health Care; Patient Care Team; Personality Assessment; Prednisone; Referral and Consultation; Schizophrenia, Paranoid; Scleroderma, Systemic; Treatment Refusal; Weight Loss | 2008 |
Steroid responsive psychotic depression.
Topics: Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Ataxia; Benzodiazepines; Depressive Disorder, Major; Doxepin; Female; Humans; Middle Aged; Olanzapine; Opioid-Related Disorders; Prednisone; Psychotic Disorders; Treatment Outcome; Vasculitis, Central Nervous System | 2009 |